TSX open
Loading markets…
Stocks/NASDAQ/INDV

Indivior PLC Ordinary Shares (INDV : NASDAQ)

Common Stock

$28.15

USD

-8.13 (-22.41%)

Last updated: 2026-11-03

💰

Dividend Declared

Yesterday

$8.1300 USD per share dividend. Ex-dividend date: November 3, 2026 • Payment date: November 6, 2026Upcoming

Follow INDV

INDV

Indivior PLC Ordinary Shares

Source:WealthAwesomeWealthAwesome
↓ $7.76 (-21.61%)
30 day period
$28.15$32.52$36.88Sep 23Oct 14Nov 3

Performance

1 Day

-22.41%

1 Week

-18.92%

1 Month

-21.17%

YTD

-25.78%

Key Statistics

Market Cap

$4.28B

52W High

$33.22

52W Low

$21.48

P/E Ratio

10.16

50 Day MA

$35.18

200 Day MA

$35.68

Beta

1.13

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/3/2026$28.35$31.62$27.97$28.15$28.157,446,175
11/2/2026$35.43$37.02$35.32$36.28$36.283,646,215
10/30/2026$34.78$36.49$34.62$35.37$35.374,607,200
10/29/2026$36.53$37.00$34.53$35.25$35.254,934,640
10/28/2026$34.39$34.86$33.84$34.77$34.771,530,302
10/27/2026$34.68$34.82$33.93$34.72$34.722,077,493
10/26/2026$34.47$34.65$33.99$34.56$34.56883,240
10/23/2026$35.34$35.34$34.10$34.47$34.471,484,000
10/22/2026$34.77$35.36$34.54$35.33$35.33871,648
10/21/2026$34.92$35.15$34.56$34.79$34.793,241,812

Analyst Price Targets

Based on 4 analysts covering INDV · as of Oct 29, 2026

📈

Wall Street analysts forecast INDV stock price to rise 75.8% over the next 12 months.

Consensus

Strong Buy

4.75 / 5.00

Avg. Target

US$49.50

+75.8% Upside

Previously US$49.00 on Oct 5, 2026

Current Price

US$28.15

Last close

Analyst Breakdown (4 analysts)

Strong Buy 3
Buy 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on INDV's historical volatility

HistoricalForecast68%95%
US$8.88US$19.58US$30.29US$40.99US$51.70US$62.41TodayJun 29Sep 1Nov 3Dec 16Jan 29Mar 13

30-Day Vol

79.1%

Annualized

90-Day Vol

51.8%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

US$23.55

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$26.52US$20.19 – US$34.84
60 trading daysUS$24.99US$16.99 – US$36.76
90 trading daysUS$23.55US$14.68 – US$37.77

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Indivior PLC Ordinary Shares

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Financials

Revenue (TTM)
$1.37B
EBITDA
$652.00M
Profit Margin
32.75%
ROE (TTM)
12.20%
EPS (Diluted)
3.57
Book Value
-0.51

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

Recent Dividends

$8.1300USD

Ex: Nov 3, 2026

Pay: Nov 6

Other

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About INDV.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
CHSNChanson International Holding Class A Ordinary Shares$3.38+241.24%
RDACRising Dragon Acquisition Corp. Ordinary Shares$11.30+121.57%
MERCMercer International Inc$0.21+68.25%
PARAParabolic Technologies, Inc.$2.72+60.95%
KTTAPasithea Therapeutics Corp$0.53+44.02%
FEEDENvue Medical Inc.$0.35+40.00%
IFBDInfobird Co Ltd$1.43+38.83%
CRMTAmericas Car-Mart Inc$1.21+32.73%

INDV.US news timeline

1 article covering INDV.US, most recent first

Latest

Indivior PLC Ordinary Shares (INDV.US) went ex-dividend — CA$8.13

•Investing